Increased expression of platelet-derived growth factor C messenger ribonucleic acid in uterine leiomyomata

Fertility and Sterility

Volumn 89, Issue 2, 2008, Pages 468-471

  Hwu, Yuh Ming ^a,b,c   Li, Sheng Hsiang ^a   Lee, Robert Kuo kuang ^a   Tsai, Yu Hui ^c   Yeh, Tien Shun ^c,d   Lin, Shyr Yeu ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; RNA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UTERUS MYOMA;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMATOSIS; LYMPHOKINES; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIGENE FAMILY; MYOMETRIUM; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; UP-REGULATION; UTERINE NEOPLASMS;

EID: 38949146061     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.02.031     Document Type: Article

References (24)

1. Buttram Jr. V.C., and Reiter R.C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36 (1981) 433-445
2. Cramer S.F., and Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 94 (1990) 435-438
3. Gambone J.C., Reiter R.C., Lench J.B., and Moore J.G. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am J Obstet Gynecol 163 (1990) 545-550
4. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 (1999) 1283-1316
5. Tsai Y.J., Lee R.K., Lin S.P., and Chen Y.H. Identification of a novel platelet-derived growth factor-like gene, fallotein, in the human reproductive tract. Biochim Biophys Acta 1492 (2000) 196-202
6. Hamada T., Ui-Tei K., and Miyata Y. A novel gene derived from developing spinal cords, SCDGF, is a unique member of the PDGF/VEGF family. FEBS Lett 475 (2000) 97-102
7. Li X., Ponten A., Aase K., Karlsson L., Abramsson A., Uutela M., et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2 (2000) 302-309
8. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C.H., et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 3 (2001) 512-516
9. Hamada T., Ui-Tei K., Imaki J., and Miyata Y. Molecular cloning of SCDGF-B, a novel growth factor homologous to SCDGF/PDGF-C/fallotein. Biochem Biophys Res Commun 280 (2001) 733-737
10. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 3 (2001) 517-521
11. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
12. De Falco M., Staibano S., D'Armiento F.P., Mascolo M., Salvatore G., Busiello A., et al. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor. J Soc Gynecol Investig 13 (2006) 297-303
13. Di Lieto A., De Rosa G., De Falco M., Iannotti F., Staibano S., Pollio F., et al. Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment. Hum Pathol 33 (2002) 220-224
14. Dou Q., Zhao Y., Tarnuzzer R.W., Rong H., Williams R.S., Schultz G.S., et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 81 (1996) 3222-3230
15. Wu X., Blanck A., Olovsson M., Moller B., and Lindblom B. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment. Acta Obstet Gynecol Scand 80 (2001) 497-504
16. Boehm K.D., Daimon M., Gorodeski I.G., Sheean L.A., Utian W.H., and Ilan J. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev 27 (1990) 93-101
17. Mangrulkar R.S., Ono M., Ishikawa M., Takashima S., Klagsbrun M., and Nowak R.A. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod 53 (1995) 636-646
18. Hoffman P.J., Milliken D.B., Gregg L.C., Davis R.R., and Gregg J.P. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 82 (2004) 639-649
19. Aoyagi Y., Oda T., Kinoshita T., Nakahashi C., Hasebe T., Ohkohchi N., et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br J Cancer 91 (2004) 1316-1326
20. Campbell J.S., Hughes S.D., Gilbertson D.G., Palmer T.E., Holdren M.S., Haran A.C., et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102 (2005) 3389-3394
21. Ponten A., Li X., Thoren P., Aase K., Sjoblom T., Ostman A., et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol 163 (2003) 673-682
22. Zhuo Y., Zhang J., Laboy M., and Lasky J.A. Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 286 (2004) L182-L188
23. Stewart E.A., Friedman A.J., Peck K., and Nowak R.A. Relative overexpression of collagen type I and type III messenger ribonucleic acids by uterine leiomyoma during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 79 (1994) 900-906
24. Arslan A.A., Gold L.I., Mittal K., Suen T.C., Belitskaya-Levy I., Tang M.S., et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20 (2005) 852-863